NCT05710796

AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 500 (actual)
• Sponsor: Kakatiya University · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

Aim of the study is to evaluate the prevalence and bring awareness ofcardiovascular complications in COVID-19 recovered patients. Study is conducted at single site, which is Srinivasa Heart Centre, Warangal, Telangana state in India for the duration of 4 months. The sample size is calculated 500 patients and the study is cohort, observational study. Patient consent has been taken before enrolment.

Detailed description

The aim of the study is to evaluate the prevalence and bring awareness of cardiovascular complications in COVID-19 recovered patients. Objectives of the study: 1. To study causes and risk factors of cardiac disorders associated with COVID-19 2. To identify different types of cardiac symptoms patients, present with 3. To study the impact of co-morbidities on COVID-19 recovered patients 4. To study treatment patterns and duration of therapy Plan to study: * To select the patient based on inclusion and exclusion criteria * To collect the patient information from case sheets and by patient interaction * To identify different types of cardiac disorders related to COVID-19 or its treatment regimen * To study the management of COVID-19 complication and related cardiovascular disorders Study Sites: Srinivasa Heart Centre, Warangal (T.S) Study Design: Observational cohort study Study Duration: 4 months Subject Eligibility: 1. Inclusion Criteria * Patients who are willing to participate * Patients having previous COVID-19 treatment record * Prescriptions reported during the study period * The prescription which is legible and complete 2. Exclusion Criteria * Patients who are not willing to participate * The patient having no history of COVID-19 and available data Source of the data: 1. Review of patient case sheet, prescription and lab reports 2. Personal interaction with patients and caregivers Sample size: 500 Patients

Conditions

• Gender Discrimination
• Cardiac Event
• Complication

Interventions

Type	Name	Description
BEHAVIORAL	Difference in gender, response to disease, diagnostic test values	Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease

Timeline

• Start date: 2021-09-01
• Primary completion: 2022-02-01
• Completion: 2022-04-29
• First posted: 2023-02-02
• Last updated: 2023-02-03

Locations

1 site across 1 country: India